Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research (2017)
- Authors:
- USP affiliated authors: LEITE, JOÃO PEREIRA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2017.00399
- Subjects: CANABINOIDES; ANSIOLÍTICOS
- Keywords: Animal models; Cannabinoids; Electrophysiology; Functional imaging; Schizophrenia; Vanilloids
- Agências de fomento:
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Processo FAPESP: 2012/23918-0 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 8, art. 399, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
RUGGIERO, Rafael N. et al. Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00399. Acesso em: 24 abr. 2024. -
APA
Ruggiero, R. N., Rossignoli, M. T., De Ross, J. B., & Hallak, J. E. C. (2017). Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00399 -
NLM
Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC. Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 abr. 24 ] Available from: https://doi.org/10.3389/fphar.2017.00399 -
Vancouver
Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC. Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 abr. 24 ] Available from: https://doi.org/10.3389/fphar.2017.00399 - What are the similarities and differences between schizophrenia and schizophrenia-like psychosis of epilepsy?: a neuropathological approach to the understanding of schizophrenia spectrum and epilepsy
- Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits
- Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities
- Pathophysiology of mood disorders in temporal lobe epilepsy
- Hippocampal expression of heat shock proteins in mesial temporal lobe epilepsy with psychiatric comorbidities and their relation to seizure outcome
- Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion
- Differential aberrant sprouting in temporal lobe epilepsy with psychiatric co-morbities
- Neurotrophin receptors expression in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with seizure type and surgical outcome
- Plasticidade Cerebral e Epileptogênese
- Neurocisticercose
Informações sobre o DOI: 10.3389/fphar.2017.00399 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
